311 related articles for article (PubMed ID: 25794157)
41. Novel WT1 Target Genes:
Dejjuy D; Dechsukhum C; Pattanapanyasat K; Noulsri E; Dissen GA; Leeanansaksiri W
Biomed Res Int; 2020; 2020():7851414. PubMed ID: 33110919
[TBL] [Abstract][Full Text] [Related]
42. Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro.
Moorwood K; Charles AK; Salpekar A; Wallace JI; Brown KW; Malik K
J Pathol; 1998 Aug; 185(4):352-9. PubMed ID: 9828833
[TBL] [Abstract][Full Text] [Related]
43. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
[TBL] [Abstract][Full Text] [Related]
44. TET enzymes are successively expressed during human spermatogenesis and their expression level is pivotal for male fertility.
Ni K; Dansranjavin T; Rogenhofer N; Oeztuerk N; Deuker J; Bergmann M; Schuppe HC; Wagenlehner F; Weidner W; Steger K; Schagdarsurengin U
Hum Reprod; 2016 Jul; 31(7):1411-24. PubMed ID: 27141042
[TBL] [Abstract][Full Text] [Related]
45. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
[TBL] [Abstract][Full Text] [Related]
47. Deletion of an intronic HIF-2α binding site suppresses hypoxia-induced WT1 expression.
Krueger K; Catanese L; Sciesielski LK; Kirschner KM; Scholz H
Biochim Biophys Acta Gene Regul Mech; 2019 Jan; 1862(1):71-83. PubMed ID: 30468780
[TBL] [Abstract][Full Text] [Related]
48. Effects of bufalin on up-regulating methylation of Wilm's tumor 1 gene in human erythroid leukemic cells.
Wang LP; Zhao YN; Sun X; Gao RL
Chin J Integr Med; 2017 Apr; 23(4):288-294. PubMed ID: 28364352
[TBL] [Abstract][Full Text] [Related]
49. WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia.
Patmasiriwat P; Fraizer G; Kantarjian H; Saunders GF
Leukemia; 1999 Jun; 13(6):891-900. PubMed ID: 10360378
[TBL] [Abstract][Full Text] [Related]
50. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
[TBL] [Abstract][Full Text] [Related]
51. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
52. [Involvement of WT1 gene expression in regulation of P53 and MDM2 proteins function in acute lymphoblastic leukemia].
Bartkowiak J; Wójcik I; Stankiewicz W
Pol Merkur Lekarski; 2001 Nov; 11(65):402-5. PubMed ID: 11852808
[TBL] [Abstract][Full Text] [Related]
53. HIF-1 directly induces TET3 expression to enhance 5-hmC density and induce erythroid gene expression in hypoxia.
Cao JZ; Liu H; Wickrema A; Godley LA
Blood Adv; 2020 Jul; 4(13):3053-3062. PubMed ID: 32634239
[TBL] [Abstract][Full Text] [Related]
54. The many facets of WT1 in acute myeloid leukemia: clarity remains elusive.
Marlton P
Leuk Lymphoma; 2014 Feb; 55(2):235-7. PubMed ID: 23697841
[No Abstract] [Full Text] [Related]
55. Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation.
Someya K; Nakatsukasa H; Ito M; Kondo T; Tateda KI; Akanuma T; Koya I; Sanosaka T; Kohyama J; Tsukada YI; Takamura-Enya T; Yoshimura A
Int Immunol; 2017 Aug; 29(8):365-375. PubMed ID: 29048538
[TBL] [Abstract][Full Text] [Related]
56. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
[TBL] [Abstract][Full Text] [Related]
57. [TET proteins and epigenetic modifications in cancers].
Ciesielski P; Jóźwiak P; Krześlak A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1371-83. PubMed ID: 26671928
[TBL] [Abstract][Full Text] [Related]
58. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
59. Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1.
Das AB; Kakadia PM; Wojcik D; Pemberton L; Browett PJ; Bohlander SK; Vissers MCM
Blood Cancer J; 2019 Oct; 9(10):82. PubMed ID: 31578317
[No Abstract] [Full Text] [Related]
60. WT1 mRNA level in peripheral blood is a sensitive biomarker for monitoring minimal residual disease in acute myeloid leukemia.
Sakamoto Y; Mariya Y; Sasaki S; Teshiromori R; Oshikiri T; Segawa M; Ogura K; Akagi T; Kubo K; Kaimori M; Funato T
Tohoku J Exp Med; 2009 Oct; 219(2):169-76. PubMed ID: 19776535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
